ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs
Ewa Sicinska(Harvard University), Matthew L. Hemming(University of Massachusetts Chan Medical School)
Cited by 10
Related Papers
Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcome
|Proceedings of the National Academy of Sciences|2018|43
Response and Mechanisms of Resistance to Larotrectinib and Selitrectinib in Metastatic Undifferentiated Sarcoma Harboring Oncogenic Fusion of <i>NTRK1</i>
|JCO Precision Oncology|2020|36
HAND1 and BARX1 Act as Transcriptional and Anatomic Determinants of Malignancy in Gastrointestinal Stromal Tumor
|Clinical Cancer Research|2021|29